scispace - formally typeset
Search or ask a question

Answers from top 3 papers

More filters
Papers (3)Insight
Substantial evidence directly implicates platelets in reocclusion and restenosis.
It also shows that apyrase can disaggregate platelets even after secondary aggregation and degranulation of platelets has taken place.
Preliminary clinical trial results suggest a favourable benefit-risk profile for remdesivir compared to placebo, however there is limited safety data available at the current time.